首页> 美国卫生研究院文献>World Journal of Gastrointestinal Endoscopy >Endoscopic and histopathological features of gastrointestinal amyloidosis
【2h】

Endoscopic and histopathological features of gastrointestinal amyloidosis

机译:胃肠道淀粉样变性病的内镜和组织病理学特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Amyloidosis is a rare disorder, characterized by the extracellular deposition of an abnormal fibrillar protein, which disrupts tissue structure and function. Amyloidosis can be acquired or hereditary, and systemic or localized to a single organ, such as the gastrointestinal (GI) tract. Clinical manifestations may vary from asymptomatic to fatal forms. Primary amyloidosis (monoclonal immunoglobulin light chains, AL) is the most common form of amyloidosis. AL amyloidosis has been associated with plasma cell dyscrasias, such as, multiple myeloma. Secondary amyloidosis is caused by the deposition of fragments of the circulating acute-phase reactant, serum amyloid A protein (SAA). Common causes of AA amyloidosis are chronic inflammatory disorders. Although GI symptoms are usually nonspecific, histopathological patterns of amyloid deposition are associated with clinical and endoscopic features. Amyloid deposition in the muscularis mucosae, submucosa, and muscularis propria has been dominant in AL amyloidosis, leading to polypoid protrusions and thickening of the valvulae conniventes, whereas granular amyloid deposition mainly in the propria mucosae has been related to AA amyloidosis, resulting in the fine granular appearance, mucosal friability, and erosions. As a result, AL amyloidosis usually presents with constipation, mechanical obstruction, or chronic intestinal pseudo-obstruction while AA amyloidosis presents with diarrhea and malabsorption Amyloidotic GI symptoms are mostly refractory and have a negative impact on quality of life and survival. Diagnosing GI amyloidosis requires high suspicion of evaluating endoscopists. Because of the absence of specific treatments for reducing the abundance of the amyloidogenic precursor protein, we should be aware of certain associations between patterns of amyloid deposition and clinical and endoscopic features.
机译:淀粉样变性病是一种罕见的疾病,其特征在于异常纤维蛋白的细胞外沉积,这会破坏组织结构和功能。淀粉样变性可以是获得性或遗传性的,并且是全身性的或局限于单个器官,例如胃肠道(GI)。临床表现可能从无症状到致命形式不等。原发性淀粉样变性病(单克隆免疫球蛋白轻链,AL)是淀粉样变性病最常见的形式。 AL淀粉样变性病已与浆细胞发育不良,例如多发性骨髓瘤有关。继发性淀粉样变性是由循环急性期反应物血清淀粉样蛋白A蛋白(SAA)的片段沉积引起的。 AA淀粉样变性的常见原因是慢性炎症性疾病。尽管胃肠道症状通常是非特异性的,但淀粉样蛋白沉积的组织病理学模式与临床和内镜特征有关。肌层粘膜,粘膜下层和固有肌层中的淀粉样蛋白沉积在AL淀粉样变性中占主导地位,导致息肉样突起和瓣膜的增厚,而颗粒状淀粉样蛋白沉积主要在固有层粘膜中与AA淀粉样变性有关,导致细小颗粒状外观,粘膜脆性和侵蚀。结果,AL淀粉样变性病通常表现为便秘,机械性梗阻或慢性肠道假性梗阻,而AA淀粉样变性病则表现为腹泻和吸收不良。淀粉样变性GI症状大多是难治性的,对生活质量和生存产生负面影响。诊断胃肠道淀粉样变性需要高度怀疑内镜医师。由于缺乏减少淀粉样蛋白生成前体蛋白丰度的特殊治疗方法,我们应该知道淀粉样蛋白沉积模式与临床和内镜特征之间的某些关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号